Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

Epidemiological evidence suggests that the incidence of ischaemic stroke in young adults
(18–50 years) has increased substantially. These patients have a long life expectancy after …

Migraine affects over a billion individuals worldwide but its genetic underpinning remains
largely unknown. Here, we performed a genome-wide association study of 102,084 …

Abstract Lasmiditan, a serotonin 5-HT1F receptor agonist, was effective for acute treatment
of patients with migraine in a phase 3 double-blind randomized controlled study. The current …

European guidelines on cardiovascular prevention in clinical practice were first published in
1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint …

Члены Комитета экспертов подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Комитета …

Migraine and stroke are two common and heterogeneous neurovascular disorders
responsible for a significant burden for those affected and a great economic cost for the …

Background Ischemic stroke is the leading cause of disability and one of the leading causes
of death. Ischemic stroke mimics (SMs) can account for a noteble number of diagnosed …

AIM: The “2024 Guideline for the Primary Prevention of Stroke” replaces the 2014
“Guidelines for the Primary Prevention of Stroke.” This updated guideline is intended to be a …

Introduction: Migraine is the most common of all neurological disorders. A breakthrough in
migraine treatment emerged in the early nineties with the introduction of 5-HT1B/D receptor …